The Motley Fool on MSN1d
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
Bad news for Novo Nordisk (NVO-17.09%) Friday was good news for Eli Lilly (LLY 4.98%) and Viking Therapeutics (VKTX 6.01%), ...
Novo Nordisk raises expectations for Eli Lilly after CagriSema slipup
Novo Nordisk (NVO) increased valuation gap with Eli Lilly (LLY) after its Phase 3 data for next-gen weight loss drug ...
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from ...
Novo Nordisk Shares Plunge After New Obesity Shot Disappoints
Novo Nordisk ’s big bet to improve on the success of its weight-loss drug franchise hit a stumbling block Friday, wiping out ...
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results ...
Novo Nordisk Crashes On Worse Than Expected Obesity Data (Rating Upgrade)
Novo Nordisk's CargiSema Phase III trial showed significant weight loss but failed reach ambitious targets set by management.
Novo Nordisk shares plummet after weight-loss drug’s disappointing trial results
Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...
Nasdaq4d
Novo Nordisk's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk (NYSE:NVO). And retail traders should know. We noticed this today when the trades showed up on publicly available ...
Novo Nordisk's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk NVO. And retail traders should know. We ...